No. | Compound | Rat Cytosol | Human Cytosol I | Human Cytosol II | Human Cytosol III |
---|---|---|---|---|---|
nmol/min/mg protein | |||||
1 | Se-ethyl-l-selenocysteine | 16.84 ± 2.40 | 0.052 ± 0.002 | 0.070 ± 0.010 | 0.048 ± 0.001 |
2 | Se-(n-propyl)-l-selenocysteine | 17.17 ± 0.51 | 0.033 ± 0.003 | 0.038 ± 0.013 | 0.042 ± 0.016 |
3 | Se-(n-butyl)-l-selenocysteine | 13.62 ± 0.32 | 0.016 ± 0.001 | 0.018 ± 0.001 | 0.028 ± 0.006 |
4 | Se-allyl-l-selenocysteine | 10.30 ± 0.20 | 0.041 ± 0.001 | 0.057 ± 0.010 | 0.087 ± 0.002 |
5 | Se-phenyl-l-selenocysteine | 17.11 ± 1.58 | 0.224 ± 0.024 | 0.318 ± 0.015 | 0.252 ± 0.006 |
6 | Se-(o-methylphenyl)-l-selenocysteine | 17.79 ± 2.13 | 0.269 ± 0.018 | 0.318 ± 0.008 | 0.206 ± 0.035 |
7 | Se-(o-chlorophenyl)-l-selenocysteine | 13.81 ± 0.23 | 0.198 ± 0.016 | 0.255 ± 0.005 | 0.249 ± 0.020 |
8 | Se-(o-methoxyphenyl)-l-selenocysteine | 9.24 ± 0.53 | 0.052 ± 0.003 | 0.085 ± 0.001 | 0.101 ± 0.016 |
9 | Se-(o-nitrophenyl)-l-selenocysteine | 7.43 ± 0.69 | 0.144 ± 0.005 | 0.242 ± 0.042 | 0.344 ± 0.023 |
10 | Se-(p-methylphenyl)-l-selenocysteine | 5.61 ± 0.05 | 0.031 ± 0.001 | 0.047 ± 0.006 | 0.034 ± 0.002 |
11 | Se-(p-methylphenyl)-d-selenocysteine | N.D. | 0.015 ± 0.001 | 0.014 ± 0.004 | 0.029 ± 0.001 |
12 | Se-(p-chlorophenyl)-l-selenocysteine | 7.97 ± 0.23 | 0.073 ± 0.010 | 0.121 ± 0.009 | 0.188 ± 0.029 |
13 | Se-(p-methoxyphenyl)-l-selenocysteine | 12.45 ± 0.80 | 0.035 ± 0.004 | 0.066 ± 0.005 | 0.079 ± 0.011 |
14 | Se-benzyl-l-selenocysteine | 16.06 ± 0.24 | 0.026 ± 0.004 | 0.060 ± 0.008 | 0.089 ± 0.016 |
15 | Se-(o-methylbenzyl)-l-selenocysteine | 8.81 ± 0.16 | 0.056 ± 0.010 | 0.076 ± 0.018 | 0.082 ± 0.004 |
16 | Se-(o-chlorobenzyl)-l-selenocysteine | 15.49 ± 2.54 | 0.083 ± 0.002 | 0.147 ± 0.016 | 0.157 ± 0.008 |
17 | Se-(o-nitrobenzyl)-l-selenocysteine | 11.83 ± 0.85 | 0.055 ± 0.008 | 0.065 ± 0.009 | 0.097 ± 0.003 |
18 | Se-(p-methylbenzyl)-l-selenocysteine | 34.72 ± 1.73 | 0.193 ± 0.008 | 0.235 ± 0.009 | 0.180 ± 0.012 |
19 | Se-(p-methylbenzyl)-d-selenocysteine | N.D. | N.D. | N.D. | 0.007 ± 0.003 |
20 | Se-(p-chlorobenzyl)-l-selenocysteine | 28.81 ± 1.51 | 0.110 ± 0.008 | 0.182 ± 0.027 | 0.095 ± 0.008 |
21 | Se-(p-methoxybenzyl)-l-selenocysteine | 18.41 ± 0.13 | 0.044 ± 0.002 | 0.075 ± 0.017 | 0.043 ± 0.001 |
22 | Se-(3,4-dichlorobenzyl)-l-selenocysteine | 17.39 ± 0.37 | 0.061 ± 0.005 | 0.092 ± 0.011 | 0.072 ± 0.001 |
23 | CTFE-cys | 25.74 ± 2.20 | 0.162 ± 0.074 | 0.154 ± 0.024 | 0.068 ± 0.016 |
Substrates were incubated at a concentration of 1.4 mM in presence of 0.5 mM KMB and rat (0.3 mg/ml) or human (3.0–5.3 mg/ml) dialyzed kidney cytosol for 5 (rat) or 20 (human) min at 37°C. Results are presented as mean ± S.D. for three preparations.
N.D., activity could not be determined due to a low turnover of the enzyme.